Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement

Noah Weisleder1, Elisavet Soumaka, Shahrzad Abbasi

  • 1Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza Texas Medical Center, Houston, TX 77030, USA.

Insights

Desmin deficiency causes heart defects in mice. Restoring desmin in cardiomyocytes prevents dilated cardiomyopathy, proving the defect is intrinsic to heart muscle cells, not blood vessels.

Area of Science:

  • Cardiovascular Biology
  • Muscle Physiology
  • Intermediate Filament Biology

Background:

  • Desmin is a muscle-specific intermediate filament protein crucial for muscle integrity.
  • Desmin deficiency in mice leads to severe cardiac defects, including dilated cardiomyopathy (DCM), myocyte death, fibrosis, and ultrastructural abnormalities.
  • Previous studies suggested potential vascular dysfunction in desmin-null hearts, but the primary cause of DCM remained unclear.

Purpose of the Study:

  • To elucidate whether dilated cardiomyopathy in desmin-null mice stems from intrinsic cardiomyocyte defects or impaired coronary vascular function.
  • To investigate the role of cardiomyocyte-specific desmin expression in rescuing cardiac phenotype.

Main Methods:

  • Generation of transgenic mice with cardiomyocyte-specific desmin rescue.
  • Assessment of cardiac phenotype, including histology (fibrosis, calcification), ultrastructure, and myocyte hypertrophy markers.
  • Functional evaluation of working hearts, measuring coronary flow and cardiac power.

Main Results:

  • Desmin rescue mice exhibited a wild-type cardiac phenotype, with normalized myocardium, absence of fibrosis and calcification, and restored coronary flow.
  • Cardiomyocyte ultrastructure and hypertrophy markers were normalized in desmin rescue mice compared to desmin-null counterparts.
  • Functional assessments confirmed improved cardiac performance in desmin-rescued hearts.

Conclusions:

  • The study demonstrates that desmin's role in the heart is intrinsic to cardiomyocytes.
  • Dilated cardiomyopathy in desmin-null mice is caused by an intrinsic cardiomyocyte defect, not by compromised coronary circulation.
  • Targeted restoration of desmin in cardiomyocytes effectively rescues the cardiac phenotype, highlighting desmin's critical function in maintaining cardiac structure and function.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...